Sophia Zoungas Selected Research

Gliclazide (Diamicron)

1/2021	The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure-Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial.
12/2020	Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all-cause mortality in individuals with type 2 diabetes in the ADVANCE trial.
1/2020	Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial.
1/2019	Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
1/2019	Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.
1/2018	Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
1/2018	Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.
1/2017	Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
1/2017	Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.
12/2016	Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophia Zoungas Research Topics

Disease

57	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2009
35	Vascular Diseases (Vascular Disease) 01/2021 - 08/2009
18	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 10/2007
14	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 05/2004
11	Chronic Renal Insufficiency 10/2020 - 10/2007
10	Myocardial Infarction 01/2022 - 03/2012
10	Stroke (Strokes) 01/2022 - 02/2013
7	Heart Failure 01/2022 - 01/2017
6	Diabetes Mellitus 01/2019 - 06/2016
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 11/2012
5	Neoplasms (Cancer) 01/2019 - 08/2012
5	Atherosclerosis 01/2019 - 06/2004
5	Albuminuria 09/2018 - 11/2012
4	Obesity 01/2022 - 08/2019
4	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 10/2010
4	Hypertension (High Blood Pressure) 01/2019 - 09/2010
4	Kidney Diseases (Kidney Disease) 05/2016 - 06/2012
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 05/2018
3	Diabetes Complications 10/2021 - 10/2015
3	Frailty 01/2021 - 07/2014
3	Inflammation (Inflammations) 01/2021 - 10/2012
3	Dementia (Dementias) 01/2021 - 01/2018
3	Coronary Disease (Coronary Heart Disease) 01/2021 - 10/2012
3	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2018 - 10/2012
3	Thrombosis (Thrombus) 05/2016 - 06/2012
2	Disease Progression 01/2022 - 11/2020
2	Genetic Risk Score 10/2021 - 01/2021
2	Cognitive Dysfunction 01/2021 - 11/2018
2	Atrial Fibrillation 01/2021 - 06/2011
2	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 09/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2016 - 10/2012
2	Hemorrhage 02/2013 - 03/2012
2	Hyperandrogenism 01/2010 - 09/2007
2	Insulin Resistance 01/2010 - 03/2007
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2010 - 03/2007
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Unstable Angina 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Myocarditis (Carditis) 01/2022
1	Prediabetic State (Prediabetes) 01/2022
1	Glucose Intolerance 01/2022
1	Overweight 01/2022
1	Cardiotoxicity 01/2022
1	Mood Disorders (Mood Disorder) 01/2021

Drug/Important Bio-Agent (IBA)

35	Gliclazide (Diamicron)IBA 01/2021 - 08/2009
35	perindopril drug combination indapamideIBA 01/2021 - 08/2009
30	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2008
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 07/2014
9	Perindopril FDA LinkGeneric 01/2019 - 11/2009
9	Indapamide FDA LinkGeneric 01/2019 - 11/2009
8	LipidsIBA 03/2022 - 01/2010
8	Blood Glucose (Blood Sugar)IBA 01/2021 - 12/2014
8	CreatinineIBA 12/2020 - 06/2011
8	Insulin (Novolin)FDA Link 11/2020 - 03/2007
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 09/2018
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2007
4	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 03/2007
4	Folic Acid (Vitamin M)FDA LinkGeneric 06/2012 - 06/2004
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2017
3	Biological ProductsIBA 01/2021 - 06/2011
3	Retinaldehyde (Retinal)IBA 01/2017 - 01/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 01/2014
3	Troponin T (Troponin T1)IBA 01/2017 - 01/2014
3	HomocysteineIBA 05/2016 - 06/2012
3	HDL CholesterolIBA 09/2013 - 06/2011
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2019
2	Pharmaceutical PreparationsIBA 12/2021 - 11/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2010
2	CholesterolIBA 01/2021 - 10/2007
2	dapagliflozinIBA 01/2021 - 01/2019
2	LDL CholesterolIBA 01/2021 - 01/2018
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 09/2018
2	ThiazolidinedionesIBA 01/2020 - 09/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 10/2014
2	AlbuminsIBA 01/2018 - 06/2011
2	C-Reactive ProteinIBA 01/2017 - 01/2010
2	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 01/2014
2	Hormones (Hormone)IBA 04/2015 - 03/2008
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2013 - 03/2012
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022
1	tirzepatideIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	CanagliflozinIBA 11/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Apolipoproteins B (ApoB)IBA 01/2021
1	Proprotein Convertase 9IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Cystatin CIBA 12/2020

Therapy/Procedure

26	Therapeutics 01/2022 - 03/2008
5	Kidney Transplantation 01/2020 - 05/2004
5	Glycemic Control 01/2020 - 01/2013
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019 - 06/2012
3	Light Coagulation 01/2017 - 01/2016
2	Surgical Amputation (Amputations) 05/2016 - 01/2016
1	Contraception (Birth Control) 01/2022
1	Duration of Therapy 11/2021
1	Injections 11/2020